Patents by Inventor Robert Field SHOEMAKER

Robert Field SHOEMAKER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RAF INHIBITOR AND KRAS G12C INHIBITOR COMBINATION THERAPY
    Publication number: 20260216199
    Abstract: A pharmaceutical combination including a Raf inhibitor which is Compound of formula (I) or a pharmaceutically acceptable salt thereof, (b) a KRAS G12C inhibitor, and/or (c) trametinib.
    Type: Application
    Filed: January 5, 2024
    Publication date: July 30, 2026
    Inventors: Wei LIN, Jonathan LIM, Shannon MORRIS, Robert Field SHOEMAKER, Jae Hyun BAE, Zachary Miles PARTON
  • COMBINATION THERAPIES FOR THE TREATMENT OF CANCER
    Publication number: 20250195533
    Abstract: The present disclosure provides methods of treating cancer with combination therapies of a SHP2 inhibitor and a KRAS G12C inhibitor.
    Type: Application
    Filed: December 10, 2021
    Publication date: June 19, 2025
    Inventors: Leenus MARTIN, Leslie Harris BRAIL, Robert Field SHOEMAKER
  • JAK INHIBITOR WITH ERK1/2 AND/OR SHP2 INHIBITORS COMBINATION THERAPY
    Publication number: 20250120978
    Abstract: The present invention relates generally to the use an ERK1/2 inhibitor or a SHP2 inhibitor alone or in combination with a JAK inhibitor for treating cancer, specifically liquid tumors such as a myeloproliferative neoplasm (MPN).
    Type: Application
    Filed: September 16, 2022
    Publication date: April 17, 2025
    Inventors: Leenus MARTIN, Robert Field SHOEMAKER, Leslie Harris BRAIL, Erin Denise LEW
  • ERK1/2 AND EGFR INHIBITORS COMBINATION THERAPY
    Publication number: 20240307392
    Abstract: The present disclosure relates generally to the use of an ERK1/2 inhibitor in combination with a EGFR inhibitor for treating cancer, specifically solid tumors. The present disclosure also relates to the use of an ERK 1/2 inhibitor in combination with a EGFR inhibitor and a BRAF inhibitor for treating cancer, specifically solid tumors.
    Type: Application
    Filed: June 23, 2022
    Publication date: September 19, 2024
    Inventors: Robert Field SHOEMAKER, Erin Denise LEW, Wei LIN, Leslie Harris BRAIL, Leenus MARTIN, Jingchuan ZHANG, Joanne OH
  • ERK1/2 AND SHP2 INHIBITORS COMBINATION THERAPY
    Publication number: 20240299388
    Abstract: The present disclosure relates generally to the use an ERK1/2 inhibitor in combination with a SHP2 inhibitor for treating cancer, specifically solid tumors.
    Type: Application
    Filed: June 23, 2022
    Publication date: September 12, 2024
    Inventors: Robert Field SHOEMAKER, Erin Denise LEW, Wei LIN, Leslie Harris BRAIL, Leenus MARTIN, Jingchuan ZHANG, Joanne OH
  • SHP2 AND CDK4/6 INHIBITORS COMBINATION THERAPIES FOR THE TREATMENT OF CANCER
    Publication number: 20240293422
    Abstract: The present disclosure provides methods of treating cancer with a combination therapy of a SHP2 inhibitor and an inhibitor of CDK4/6.
    Type: Application
    Filed: June 23, 2022
    Publication date: September 5, 2024
    Inventors: Leenus MARTIN, Leslie Harris BRAIL, Robert Field SHOEMAKER
  • ERK1/2 AND KRAS G12C INHIBITORS COMBINATION THERAPY
    Publication number: 20240285625
    Abstract: The present disclosure relates generally to the use of an ERK 1/2 inhibitor in combination with a KRAS G12C inhibitor for treating cancer, specifically solid tumors.
    Type: Application
    Filed: June 23, 2022
    Publication date: August 29, 2024
    Inventors: Robert Field SHOEMAKER, Erin Denise LEW, Wei LIN, Jingchuan ZHANG, Joanne OH
  • ERK1/2 OR SHP2 INHIBITORS AND FLT3 INHIBITORS COMBINATION THERAPY
    Publication number: 20240285624
    Abstract: The present disclosure relates generally to the use of an ERK1/2 inhibitor or a SHP2 inhibitor in combination with a FLT3 inhibitor, such as gilteritinib, for treating cancer, specifically acute myeloid leukemia (AML).
    Type: Application
    Filed: June 23, 2022
    Publication date: August 29, 2024
    Inventors: Robert Field SHOEMAKER, Wei LIN, Erin Denise LEW, Jingchuan ZHANG, Joanne OH, Leenus MARTIN, Leslie Harris BRAIL
  • COMBINATION THERAPIES FOR THE TREATMENT OF CANCER
    Publication number: 20240058352
    Abstract: The present disclosure provides methods of treating cancer with a combination therapies of a SHP2 inhibitor, such as the compound of Formula I, and an FGFR inhibitor, a B-Raf inhibitor, a MEK inhibitor, or a MET inhibitor
    Type: Application
    Filed: December 10, 2021
    Publication date: February 22, 2024
    Inventors: Leenus MARTIN, Leslie Harris BRAIL, Robert Field SHOEMAKER
  • COMBINATION THERAPIES FOR THE TREATMENT OF CANCER
    Publication number: 20240050441
    Abstract: The present disclosure provides methods of treating cancer with combination therapies of a SHP2 inhibitor and EGFR inhibitor.
    Type: Application
    Filed: December 10, 2021
    Publication date: February 15, 2024
    Inventors: Leenus MARTIN, Leslie Harris BRAIL, Robert Field SHOEMAKER